A R Ramzy1, S Nausheen1, P K Chelikani2. 1. Department of Production Animal Health, Faculty of Veterinary Medicine, Alberta, Calgary, Canada. 2. 1] Department of Production Animal Health, Faculty of Veterinary Medicine, Alberta, Calgary, Canada [2] Gastrointestinal Research Group, Calvin, Phoebe and Joan Snyder Institute for Chronic Diseases, University of Calgary, Alberta, Calgary, Canada.
Abstract
BACKGROUND: Enhanced stimulation of the lower gut is hypothesized to play a key role in the weight loss and resolution of diabetes following bariatric surgeries. Ileal transposition (IT) permits study of the effects of direct lower gut stimulation on body weight, glucose homeostasis and other metabolic adaptations without the confounds of gastric restriction or foregut exclusion. However, the underlying mechanisms and the length of the ileum sufficient to produce metabolic benefits following IT surgery remain largely unknown. OBJECTIVE: To determine the effects of transposing varying lengths of the ileum to upper jejunum on food intake, body weight, glucose tolerance and lower gut hormones, and the expression of key markers of glucose and lipid metabolism in skeletal muscle and adipose tissue in rats. METHODS: Adult male Sprague-Dawley rats (n=9/group) were subjected to IT surgery with translocation of 5, 10 or 20 cm of the ileal segment to proximal jejunum or sham manipulations. Daily food intake and body weight were recorded, and an intraperitoneal glucose tolerance test was performed. Blood samples were assayed for hormones and tissue samples for mRNA (RT-qPCR) and/or protein abundance (immunoblotting) of regulatory metabolic markers. RESULTS: We demonstrate that IT surgery exerts ileal length-dependent effects on multiple parameters including: (1) decreased food intake and weight gain, (2) improved glucose tolerance, (3) increased tissue expression and plasma concentrations of glucagon-like peptide-1 (GLP-1) and peptide YY (PYY), and decreased leptin concentrations and (4) upregulation of key markers of glucose metabolism (glucose transporter-4 (GLUT-4), insulin receptor substrate 1 (IRS-1), adenosine monophosphate-activated protein kinase (AMPK), hexokinase (HK) and phosphofructokinase (PFK)) together with a downregulation of lipogenic markers (fatty acid synthase (FAS)) in muscle and adipose tissue. CONCLUSIONS: Together, our data demonstrate that the reduction in food intake and weight gain, increase in lower gut hormones, glycemic improvements and associated changes in tissue metabolic markers following IT surgery are dependent on the length of the transposed ileum.
BACKGROUND: Enhanced stimulation of the lower gut is hypothesized to play a key role in the weight loss and resolution of diabetes following bariatric surgeries. Ileal transposition (IT) permits study of the effects of direct lower gut stimulation on body weight, glucose homeostasis and other metabolic adaptations without the confounds of gastric restriction or foregut exclusion. However, the underlying mechanisms and the length of the ileum sufficient to produce metabolic benefits following IT surgery remain largely unknown. OBJECTIVE: To determine the effects of transposing varying lengths of the ileum to upper jejunum on food intake, body weight, glucose tolerance and lower gut hormones, and the expression of key markers of glucose and lipid metabolism in skeletal muscle and adipose tissue in rats. METHODS: Adult male Sprague-Dawley rats (n=9/group) were subjected to IT surgery with translocation of 5, 10 or 20 cm of the ileal segment to proximal jejunum or sham manipulations. Daily food intake and body weight were recorded, and an intraperitoneal glucose tolerance test was performed. Blood samples were assayed for hormones and tissue samples for mRNA (RT-qPCR) and/or protein abundance (immunoblotting) of regulatory metabolic markers. RESULTS: We demonstrate that IT surgery exerts ileal length-dependent effects on multiple parameters including: (1) decreased food intake and weight gain, (2) improved glucose tolerance, (3) increased tissue expression and plasma concentrations of glucagon-like peptide-1 (GLP-1) and peptide YY (PYY), and decreased leptin concentrations and (4) upregulation of key markers of glucose metabolism (glucose transporter-4 (GLUT-4), insulin receptor substrate 1 (IRS-1), adenosine monophosphate-activated protein kinase (AMPK), hexokinase (HK) and phosphofructokinase (PFK)) together with a downregulation of lipogenic markers (fatty acid synthase (FAS)) in muscle and adipose tissue. CONCLUSIONS: Together, our data demonstrate that the reduction in food intake and weight gain, increase in lower gut hormones, glycemic improvements and associated changes in tissue metabolic markers following IT surgery are dependent on the length of the transposed ileum.
Authors: Lori Asarian; Kathrin Abegg; Nori Geary; Marc Schiesser; Thomas A Lutz; Marco Bueter Journal: Gastroenterology Date: 2012-05-15 Impact factor: 22.682
Authors: Aureo Ludovico De Paula; Alessandro R Stival; Alfredo Halpern; Carolina C L DePaula; Andrea Mari; Elza Muscelli; Sergio Vencio; Ele Ferrannini Journal: J Gastrointest Surg Date: 2011-05-10 Impact factor: 3.452
Authors: Sandra Bonhomme; Ana Guijarro; Stefan Keslacy; Carolina G Goncalves; Susumu Suzuki; Chung Chen; Michael M Meguid Journal: Nutrition Date: 2011-01 Impact factor: 4.008
Authors: Tian Tian Wang; San Yuan Hu; Hai Dong Gao; Guang Yong Zhang; Chong Zhong Liu; Jin Bo Feng; Eldo E Frezza Journal: Ann Surg Date: 2008-06 Impact factor: 12.969
Authors: Alberto Patriti; Maria Cristina Aisa; Claudia Annetti; Angelo Sidoni; Francesco Galli; Ivana Ferri; Nino Gullà; Annibale Donini Journal: Surgery Date: 2007-07 Impact factor: 3.982
Authors: Adrian J Green; James L Graham; Eduardo A Gonzalez; Michael R La Frano; Syrago-Styliani E Petropoulou; June-Soo Park; John W Newman; Kimber L Stanhope; Peter J Havel; Michele A La Merrill Journal: Reprod Toxicol Date: 2016-07-12 Impact factor: 3.143
Authors: Christian Ferdinand Jurowich; Christoph Otto; Prashanth Reddy Rikkala; Nicole Wagner; Ivana Vrhovac; Ivan Sabolić; Christoph-Thomas Germer; Hermann Koepsell Journal: J Diabetes Res Date: 2015-06-22 Impact factor: 4.011